 Combined treatment with all-trans-retinoic acid and chemotherapy is extremely efficient in patients with acute promyelocytic leukemia with t(15;17)/PML-RARA, but up to 15% of patients relapse.     ///    Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA.. 